GOLDBERG CAROL R 4
4 · ALERE INC. · Filed Oct 3, 2017
Insider Transaction Report
Form 4
ALERE INC.ALR
GOLDBERG CAROL R
Director
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−41,685→ 0 totalExercise: $33.73→ Common Stock (41,685 underlying) - Disposition to Issuer
Common Stock
2017-10-03−44,597→ 0 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2017-10-03−40,614→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−33,515→ 0 totalExercise: $29.55→ Common Stock (33,515 underlying)
Footnotes (3)
- [F1]Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration").
- [F2]Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option.
- [F3]These securities are held by The Carol R. Goldberg Qualified Annuity Trust - 2014, of which the reporting person is the trustee; the Avram J. Goldberg and Carol R. Goldberg Charitable Remainder Unitrust, of which the reporting person and her spouse are the trustees; and the Sydney R. Rabb Trust f/b/o Carol R. Goldberg, of which the reporting person, along with another unrelated individuals, are the trustees.